WSJ News Exclusive | Generic Drugs Should Be Cheap, but Insurers Are Charging Thousands of Dollars for Them
Health insurers mark up prices of generics for cancer, multiple sclerosis and other complicated diseases
Related Articles
At Moderna, OpenAI’s GPTs Are Changing Almost Everything
“People literally talk about how AI is going to cure diseases someday, and I think this is a very meaningful first step,” said OpenAI CEO…
Millions of American Kids Are Caregivers Now: ‘The Hardest Part Is That I’m Only 17’
An estimated 5.4 million children help care for relatives, as families can’t afford or find other in-home care.
Opinion | An Au Pair Could Take Care of Grandma
The administration should expand, not restrict, the program.
Is Your Cancer Test Accurate? The FDA Wants to Make Sure
A new rule details how the agency will oversee the $10 billion industry for medical tests conducted by single laboratories.
Less Is More: The Case for ‘Slow Productivity’ at Work
We’re thinking about productivity at work all wrong, Cal Newport says. But how do we tell the boss that?
Star Scientist’s Claim of ‘Reverse Aging’ Draws Hail of Criticism
Other longevity researchers have rebuked the Harvard geneticist. “The selling is a step too far,” said one.
Opinion | On Columbia University and Coach Handbags
A degree’s value, in both money and status, depends on the reputation of the institution’s brand.
The New, More-Hopeful Face of Alzheimer’s Disease
Advances in early detection and management of the disease have changed the way patients view an Alzheimer’s diagnosis—and how they live with it.
Star Scientist’s Claim of ‘Reverse Aging’ Draws Hail of Criticism
Other longevity researchers have rebuked the Harvard geneticist. “The selling is a step too far,” said one.
Star Scientist’s Claim of ‘Reverse Aging’ Draws Hail of Criticism
Other longevity researchers have rebuked the Harvard geneticist. “The selling is a step too far,” said one.
